Source:http://linkedlifedata.com/resource/pubmed/id/18268203
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0003-9942
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
282-3
|
pubmed:meshHeading |
pubmed-meshheading:18268203-Brain,
pubmed-meshheading:18268203-Graves Disease,
pubmed-meshheading:18268203-Hashimoto Disease,
pubmed-meshheading:18268203-Humans,
pubmed-meshheading:18268203-Iodine Radioisotopes,
pubmed-meshheading:18268203-Magnetic Resonance Imaging,
pubmed-meshheading:18268203-Male,
pubmed-meshheading:18268203-Middle Aged,
pubmed-meshheading:18268203-Neurotoxicity Syndromes
|
pubmed:year |
2008
|
pubmed:articleTitle |
Hashimoto encephalopathy following iodine 131 (131 I) radiotherapy of Graves disease.
|
pubmed:publicationType |
Letter,
Case Reports
|